BioSpace News Archive

Ardelyx, Inc., a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, announced that Geoffrey Block, MD, is stepping down from the Board of Directors after nearly five years of service.

Rhythm Pharmaceuticals, Inc. announced that on November 8, 2023, the Compensation Committee of Rhythm’s board of directors granted inducement equity grants covering an aggregate of 6,765 shares of its common stock to two new employees, consisting of inducement stock options to purchase an aggregate of 4,510 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 2,255 shares of its common stock.

INVO Bioscience, Inc. announced financial results for the third quarter ended September 30, 2023 and provided a business update.

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX) today announced the presentation of new results from the ongoing Phase 2b clinical trial of VK2809, the company’s novel liver-selective thyroid hormone receptor beta agonist, in patients with biopsy-confirmed non-alcoholic steatohepatitis (NASH).

Apollo Medical Holdings, Inc. announced that leadership is participating in the BTIG Digital Health Forum, being held virtually, on Monday, November 20, 2023, including a panel discussion with Brandon Sim, Co-Chief Executive Officer, at 12:00 p.m. PT/3:00 p.m. ET.

ThermoGenesis Holdings, Inc. reported financial and operating results for the third quarter ended September 30, 2023, and provided a corporate business update.

Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financial results for the third quarter ended September 30, 2023.

CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Piper Sandler Healthcare Conference at 9:00 a.m. ET on Tuesday, November 28, 2023.

Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, announced that President and Chief Executive Officer Masoud Toloue will speak in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 16, 2023 at 3:00 PM ET.

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and oncologic disorders, today reported financial results for the third quarter ended September 30, 2023 and provided a business update.